IAM Life Sciences 2017

The key IP issues that entities operating in the pharmaceutical and biotechnology industries may confront as they develop and roll out their business strategies.

Articles

Patent pools in the life sciences: a potential facilitator of CRISPR commercialisation

COHAUSZ & FLORACK


Ralph Minderop, Natalie Kirchhofer and Lauren Schweizer

Protection and enforcement of second medical use claims

Grünecker Patent Attorneys and Attorneys-at-Law


Markus Grammel and Heike Vogelsang-Wenke

Patent eligibility and life sciences patents

Kirkland & Ellis LLP


Leora Ben-Ami and Thomas Fleming

Implications of recent life sciences cases in China

Liu, Shen & Associates


Guojun (Jason) Liu and Zongliang (Stephen) Zou

Importing plants into India: processes and challenges

Obhan & Associates


Essenese Obhan and Charul Yadav

Pharmaceutical patents in Canada: key issues for life sciences companies

Smart & Biggar / Fetherstonhaugh


Yoon Kang and Daphne Lainson

Patenting stem cells and genes in Europe

Weickmann & Weickmann Patentanwälte-Rechtsanwalt PartmbB


Wolfgang Weiss and Christian Heubeck

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 84